General enquiries

+44 (0) 20 7079 4399

Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat


Clinical Trials


Giving your cancer patients access to early clinical trials
HCA are working with Sarah Cannon Research UK to provide early access to novel therapies in world-class clinical trials. Sarah Cannon Research UK  is part of the Sarah Cannon Research Institute (SCRI), an international strategic research organisation focusing on advancing therapies for patients and accelerating drug development.

• One of the world’s largest clinical research programmes.
• More than 700 oncologists / haematologists across the US and UK.
• The only UK private centre conducting Phase I to III clinical trials.
The partnership between HCA and Sarah Cannon Research UK means that we are the only private hospital group in the UK who can offer your patients the opportunity to take part in early clinical trials for new cancer treatments.

The Harley Street Clinic
The Lister Hospital
London Bridge Hospital
The Portland Hospital
The Princess Grace Hospital
Wellington hospital
Harley Street at University College Hospital
Harley Street Queens
The Christie Clinic
Sarah Cannon Research UK
Blossoms Healthcare
Roodlane Medical
Galen Health Partners
52 Alderley Road
The London Gamma Knife Centre at St Bartholomew's
HCA Healthcare UK

© copyright 2008 - 2016 HCA Healthcare UK.

Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.